287 related articles for article (PubMed ID: 26872090)
21. Immunohistochemical analysis of human orbital tissue in Graves' orbitopathy.
Hai YP; Lee ACH; Frommer L; Diana T; Kahaly GJ
J Endocrinol Invest; 2020 Feb; 43(2):123-137. PubMed ID: 31538314
[TBL] [Abstract][Full Text] [Related]
22. Experimental model for ophthalmopathy in BALB/c and outbred (CD-1) mice genetically immunized with G2s and the thyrotropin receptor.
Yamada M; Li AW; West KA; Chang CH; Wall JR
Autoimmunity; 2002 Sep; 35(6):403-13. PubMed ID: 12568121
[TBL] [Abstract][Full Text] [Related]
23. Enhanced orbital adipogenesis in a mouse model of T-cell-mediated autoimmunity, zymosan A-treated SKG mice: Implications for Graves' ophthalmopathy.
Park S; Park DY; Kim J; Woo KI; Kim YD; Han J; Chung TY; Cha HS; Lim DH
Sci Rep; 2020 Apr; 10(1):7329. PubMed ID: 32355208
[TBL] [Abstract][Full Text] [Related]
24. A stimulatory thyrotropin receptor antibody (M22) and thyrotropin increase interleukin-6 expression and secretion in Graves' orbital preadipocyte fibroblasts.
Kumar S; Schiefer R; Coenen MJ; Bahn RS
Thyroid; 2010 Jan; 20(1):59-65. PubMed ID: 20017620
[TBL] [Abstract][Full Text] [Related]
25. Forkhead Transcription Factor FOXO1 Is Regulated by Both a Stimulatory Thyrotropin Receptor Antibody and Insulin-Like Growth Factor-1 in Orbital Fibroblasts from Patients with Graves' Ophthalmopathy.
Kumar S; Coenen M; Iyer S; Bahn RS
Thyroid; 2015 Oct; 25(10):1145-50. PubMed ID: 26213859
[TBL] [Abstract][Full Text] [Related]
26. Current Insights into the Pathogenesis of Graves' Ophthalmopathy.
Bahn RS
Horm Metab Res; 2015 Sep; 47(10):773-8. PubMed ID: 26361262
[TBL] [Abstract][Full Text] [Related]
27. Pathogenesis of thyroid eye disease--does autoimmunity against the TSH receptor explain all cases?
Wall JR; Lahooti H
Endokrynol Pol; 2010; 61(2):222-7. PubMed ID: 20464711
[TBL] [Abstract][Full Text] [Related]
28. Human placenta-derived mesenchymal stem cells ameliorate orbital adipogenesis in female mice models of Graves' ophthalmopathy.
Park M; Banga JP; Kim GJ; Kim M; Lew H
Stem Cell Res Ther; 2019 Aug; 10(1):246. PubMed ID: 31399042
[TBL] [Abstract][Full Text] [Related]
29. Rituximab treatment in patients with active Graves' orbitopathy: effects on proinflammatory and humoral immune reactions.
Vannucchi G; Campi I; Bonomi M; Covelli D; Dazzi D; Currò N; Simonetta S; Bonara P; Persani L; Guastella C; Wall J; Beck-Peccoz P; Salvi M
Clin Exp Immunol; 2010 Sep; 161(3):436-43. PubMed ID: 20529087
[TBL] [Abstract][Full Text] [Related]
30. Antigen-specific therapy of Graves´ disease and orbitopathy by induction of tolerance.
Ungerer M; Fabbender J; Holthoff HP
Front Biosci (Landmark Ed); 2018 Jun; 23(11):2044-2052. PubMed ID: 29772544
[TBL] [Abstract][Full Text] [Related]
31. [Establishment of an animal model for thyroid associated ophthalmopathy by treatment of mice with human thyrotropin receptors-activated splenocytes].
Zhang L; Liu C; Zhang H; He Y; Zhan SH
Zhonghua Yan Ke Za Zhi; 2006 Dec; 42(12):1073-7. PubMed ID: 17415963
[TBL] [Abstract][Full Text] [Related]
32. Interleukin 10 deficiency attenuates induction of anti-TSH receptor antibodies and hyperthyroidism in a mouse Graves' model.
Ueki I; Abiru N; Kawagoe K; Nagayama Y
J Endocrinol; 2011 Jun; 209(3):353-7. PubMed ID: 21474590
[TBL] [Abstract][Full Text] [Related]
33. Is There Evidence for IGF1R-Stimulating Abs in Graves' Orbitopathy Pathogenesis?
Krieger CC; Neumann S; Gershengorn MC
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911689
[TBL] [Abstract][Full Text] [Related]
34. "Hijacking" the thyrotropin receptor: A chimeric receptor-lysosome associated membrane protein enhances deoxyribonucleic acid vaccination and induces Graves' hyperthyroidism.
Pichurin PN; Chazenbalk GD; Aliesky H; Pichurina O; Rapoport B; McLachlan SM
Endocrinology; 2004 Dec; 145(12):5504-14. PubMed ID: 15331574
[TBL] [Abstract][Full Text] [Related]
35. Adoptive transfer of antithyrotropin receptor (TSHR) autoimmunity from TSHR knockout mice to athymic nude mice.
Nakahara M; Johnson K; Eckstein A; Taguchi R; Yamada M; Abiru N; Nagayama Y
Endocrinology; 2012 Apr; 153(4):2034-42. PubMed ID: 22334716
[TBL] [Abstract][Full Text] [Related]
36. Role of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves' orbitopathy.
Smith TJ; Hegedüs L; Douglas RS
Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):291-302. PubMed ID: 22632366
[TBL] [Abstract][Full Text] [Related]
37. Examination of orbital tissues in murine models of Graves' disease reveals expression of UCP-1 and the TSHR in retrobulbar adipose tissues.
Johnson KT; Wiesweg B; Schott M; Ehlers M; Müller M; Minich WB; Nagayama Y; Gulbins E; Eckstein AK; Berchner-Pfannschmidt U
Horm Metab Res; 2013 Jun; 45(6):401-7. PubMed ID: 23386414
[TBL] [Abstract][Full Text] [Related]
38. Insight into Graves' hyperthyroidism from animal models.
McLachlan SM; Nagayama Y; Rapoport B
Endocr Rev; 2005 Oct; 26(6):800-32. PubMed ID: 15827111
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms That Underly T Cell Immunity in Graves' Orbitopathy.
Fang S; Lu Y; Huang Y; Zhou H; Fan X
Front Endocrinol (Lausanne); 2021; 12():648732. PubMed ID: 33868176
[TBL] [Abstract][Full Text] [Related]
40. Pathogenesis of ophthalmopathy in autoimmune thyroid disease.
Heufelder AE
Rev Endocr Metab Disord; 2000 Jan; 1(1-2):87-95. PubMed ID: 11704996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
